ZBTB6
gene geneOn this page
Also known as ZID
Summary
ZBTB6 (zinc finger and BTB domain containing 6, HGNC:16764) is a protein-coding gene on chromosome 9q33.2, encoding Zinc finger and BTB domain-containing protein 6 (Q15916). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Located in mitochondrion and nucleoplasm.
Source: NCBI Gene 10773 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 35 total
- MANE Select transcript:
NM_006626
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16764 |
| Approved symbol | ZBTB6 |
| Name | zinc finger and BTB domain containing 6 |
| Location | 9q33.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZID |
| Ensembl gene | ENSG00000186130 |
| Ensembl biotype | protein_coding |
| OMIM | 605976 |
| Entrez | 10773 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000373659, ENST00000899189, ENST00000899190, ENST00000915652
RefSeq mRNA: 1 — MANE Select: NM_006626
NM_006626
CCDS: CCDS6846
Canonical transcript exons
ENST00000373659 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001377956 | 122913251 | 122913323 |
| ENSE00001461163 | 122908056 | 122912081 |
Expression profiles
Bgee: expression breadth ubiquitous, 182 present calls, max score 88.34.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.0690 / max 227.7270, expressed in 1715 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 102399 | 12.0690 | 1715 |
Top tissues by expression
282 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 88.34 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.66 | gold quality |
| ganglionic eminence | UBERON:0004023 | 81.59 | gold quality |
| islet of Langerhans | UBERON:0000006 | 80.66 | gold quality |
| ventricular zone | UBERON:0003053 | 78.27 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.75 | silver quality |
| stromal cell of endometrium | CL:0002255 | 77.72 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.57 | gold quality |
| muscle of leg | UBERON:0001383 | 76.63 | gold quality |
| gastrocnemius | UBERON:0001388 | 76.23 | gold quality |
| rectum | UBERON:0001052 | 76.07 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 75.42 | gold quality |
| granulocyte | CL:0000094 | 75.03 | gold quality |
| lymph node | UBERON:0000029 | 75.03 | gold quality |
| leukocyte | CL:0000738 | 74.76 | gold quality |
| monocyte | CL:0000576 | 74.56 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 74.16 | gold quality |
| mononuclear cell | CL:0000842 | 74.11 | gold quality |
| gall bladder | UBERON:0002110 | 73.93 | gold quality |
| pancreas | UBERON:0001264 | 73.43 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 73.35 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 73.23 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 73.04 | gold quality |
| vermiform appendix | UBERON:0001154 | 72.95 | gold quality |
| right adrenal gland | UBERON:0001233 | 72.62 | gold quality |
| left adrenal gland | UBERON:0001234 | 72.60 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 72.25 | gold quality |
| prefrontal cortex | UBERON:0000451 | 72.21 | gold quality |
| body of pancreas | UBERON:0001150 | 72.20 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 72.03 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6058 | no | 134.36 |
| E-ANND-3 | no | 2.30 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1581.1 | ZBTB6 | More than 3 adjacent zinc fingers |
| MA1581.2 | ZBTB6 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:16381825
miRNA regulators (miRDB)
178 targeting ZBTB6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zbtb6 | ENSMUSG00000066798 |
| rattus_norvegicus | Zbtb6 | ENSRNOG00000009340 |
Paralogs (28): ZNF280C (ENSG00000056277), ZBTB25 (ENSG00000089775), PRDM13 (ENSG00000112238), BCL6 (ENSG00000113916), FEZF1 (ENSG00000128610), ZBTB46 (ENSG00000130584), PRDM12 (ENSG00000130711), ZNF280D (ENSG00000137871), NACC2 (ENSG00000148411), FEZF2 (ENSG00000153266), ZBTB7B (ENSG00000160685), NACC1 (ENSG00000160877), BCL6B (ENSG00000161940), GFI1 (ENSG00000162676), GFI1B (ENSG00000165702), ZBTB49 (ENSG00000168826), ZNF280A (ENSG00000169548), ZNF581 (ENSG00000171425), ZNF524 (ENSG00000171443), ZBTB26 (ENSG00000171448), ZBTB21 (ENSG00000173276), ZNF683 (ENSG00000176083), ZBTB33 (ENSG00000177485), ZBTB3 (ENSG00000185670), ZBTB14 (ENSG00000198081), ZBTB12 (ENSG00000204366), ZNF580 (ENSG00000213015), ZNF280B (ENSG00000275004)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 6 — Q15916 (reviewed: Q15916)
Alternative names: Zinc finger protein 482, Zinc finger protein with interaction domain
All UniProt accessions (1): Q15916
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Tissue specificity. Widely expressed with highest levels in brain.
RefSeq proteins (1): NP_006617* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050457 | ZnFinger_BTB_dom_contain | Family |
Pfam: PF00096, PF00651
UniProt features (9 total): zinc finger region 4, chain 1, domain 1, region of interest 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q15916-F1 | 59.18 | 0.10 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 202
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 123 (showing top):
TTTGTAG_MIR520D, BROWNE_HCMV_INFECTION_16HR_UP, GTGCCTT_MIR506, MODULE_285, GOBP_CYTOKINE_PRODUCTION, ACATTCC_MIR1_MIR206, DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP, CTTTGTA_MIR524, AACATTC_MIR4093P, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of cytokine production (GO:0001817), regulation of immune system process (GO:0002682)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (3): nucleus (GO:0005634), nucleoplasm (GO:0005654), mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| intracellular membrane-bounded organelle | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| cytokine production | 1 |
| regulation of gene expression | 1 |
| regulation of multicellular organismal process | 1 |
| immune system process | 1 |
| regulation of biological process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
686 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB6 | ACTA1 | P02568 | 762 |
| ZBTB6 | ANP32E | Q9BTT0 | 509 |
| ZBTB6 | KLHL18 | O94889 | 403 |
| ZBTB6 | HDAC2 | Q92769 | 388 |
| ZBTB6 | ZSCAN1 | Q8NBB4 | 377 |
| ZBTB6 | KCTD2 | Q14681 | 351 |
| ZBTB6 | BTBD7 | Q9P203 | 347 |
| ZBTB6 | TMEM106A | Q96A25 | 334 |
| ZBTB6 | C11orf71 | Q6IPW1 | 324 |
| ZBTB6 | FAM110B | Q8TC76 | 324 |
| ZBTB6 | UBAC1 | Q9BSL1 | 318 |
| ZBTB6 | TRMT2B | Q96GJ1 | 292 |
| ZBTB6 | FERRY3 | Q9NQ89 | 290 |
| ZBTB6 | ANKFY1 | Q9P2R3 | 288 |
| ZBTB6 | L3MBTL3 | Q96JM7 | 278 |
IntAct
40 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZBTB6 | ZBTB26 | psi-mi:“MI:0915”(physical association) | 0.720 |
| SUMO1P1 | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB6 | SUMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB6 | SUMO1P1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SUMO1 | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB6 | PLEKHF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF250 | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB6 | FAM9A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB48 | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF4 | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRKN | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| VHL | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB6 | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SKIL | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ATF7IP | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZBTB6 | ZBTB26 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PLEKHF2 | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF250 | ZBTB6 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZBTB6 | FAM9A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (15): ZBTB6 (Two-hybrid), ZBTB26 (Two-hybrid), SUMO1P1 (Two-hybrid), SAR1B (Affinity Capture-MS), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZNF250 (Two-hybrid), ZBTB48 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Two-hybrid), ZBTB6 (Affinity Capture-Western), ZBTB6 (Two-hybrid)
ESM2 similar proteins: A0JN76, A1L2U9, B1WAZ8, B1WBU4, O15060, O35260, O43298, O93567, P14404, P41182, P41183, Q05516, Q0IH98, Q0IJ29, Q0P4X6, Q0V8G8, Q0VCJ6, Q15916, Q1L8W0, Q3B725, Q3SWU4, Q5TC79, Q5ZM39, Q6NRM8, Q6P882, Q6YND2, Q7TQG0, Q7TSZ8, Q7ZWZ4, Q801P1, Q80X44, Q86UZ6, Q8BID6, Q8CII0, Q8K088, Q8K0L9, Q8N680, Q8NAP8, Q8NCN2, Q8NCP5
Diamond homologs: A0JMG1, A1YPR0, B0WWP2, B1WBS3, B2RXF5, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, D3Z8N4, E0CZ16, E1B932, E7F6F9, E9Q4F2, F1LZ52, F1LZF0, F1MBP6, O14682, O15060, O35709, O43791, O88939, O93567, O94889, O95198, O95365, P0DMR5, P34568, P41182, P41183, Q04652, Q08DK3, Q0D2A9, Q0IHH9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
35 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 32 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
194 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:122912078:CAAT:C | acceptor_gain | 0.9900 |
| 9:122913250:CCGA:C | donor_gain | 0.9900 |
| 9:122913244:CACT:C | donor_loss | 0.9800 |
| 9:122913245:A:AC | donor_gain | 0.9800 |
| 9:122913246:C:CC | donor_gain | 0.9800 |
| 9:122913247:T:TA | donor_loss | 0.9800 |
| 9:122913248:C:CC | donor_loss | 0.9800 |
| 9:122913249:A:AC | donor_gain | 0.9800 |
| 9:122913250:C:CC | donor_gain | 0.9800 |
| 9:122913246:CTCA:C | donor_gain | 0.9700 |
| 9:122913245:AC:A | donor_loss | 0.9500 |
| 9:122913246:CT:C | donor_gain | 0.9400 |
| 9:122912082:C:CC | acceptor_gain | 0.9300 |
| 9:122912079:AATCT:A | acceptor_loss | 0.9200 |
| 9:122912080:ATCT:A | acceptor_loss | 0.9200 |
| 9:122912081:TCTA:T | acceptor_loss | 0.9200 |
| 9:122912082:C:CG | acceptor_loss | 0.9200 |
| 9:122912083:T:A | acceptor_loss | 0.9200 |
| 9:122913248:CACCG:C | donor_gain | 0.9100 |
| 9:122913249:ACCGA:A | donor_gain | 0.9100 |
| 9:122913250:CCGAC:C | donor_gain | 0.9100 |
| 9:122912929:TC:T | donor_gain | 0.9000 |
| 9:122912930:CC:C | donor_gain | 0.9000 |
| 9:122912936:C:A | donor_gain | 0.9000 |
| 9:122912097:C:CT | acceptor_loss | 0.8900 |
| 9:122911435:TTAAA:T | donor_gain | 0.8700 |
| 9:122913243:TCAC:T | donor_loss | 0.8700 |
| 9:122912935:T:TA | donor_gain | 0.8600 |
| 9:122913250:CCG:C | donor_gain | 0.8600 |
| 9:122912084:A:C | acceptor_loss | 0.8400 |
AlphaMissense
2833 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:122910875:G:C | H400D | 1.000 |
| 9:122910883:A:G | L397P | 1.000 |
| 9:122910900:G:C | F391L | 1.000 |
| 9:122910900:G:T | F391L | 1.000 |
| 9:122910901:A:G | F391S | 1.000 |
| 9:122910902:A:G | F391L | 1.000 |
| 9:122910923:A:G | C384R | 1.000 |
| 9:122910945:G:C | H376Q | 1.000 |
| 9:122910945:G:T | H376Q | 1.000 |
| 9:122910957:G:C | H372Q | 1.000 |
| 9:122910957:G:T | H372Q | 1.000 |
| 9:122910959:G:C | H372D | 1.000 |
| 9:122910959:G:T | H372N | 1.000 |
| 9:122910967:A:G | L369P | 1.000 |
| 9:122910984:A:C | F363L | 1.000 |
| 9:122910984:A:T | F363L | 1.000 |
| 9:122910985:A:G | F363S | 1.000 |
| 9:122910986:A:G | F363L | 1.000 |
| 9:122910996:G:C | C359W | 1.000 |
| 9:122910998:A:G | C359R | 1.000 |
| 9:122911005:A:C | C356W | 1.000 |
| 9:122911007:A:G | C356R | 1.000 |
| 9:122911011:A:C | F354L | 1.000 |
| 9:122911011:A:T | F354L | 1.000 |
| 9:122911013:A:G | F354L | 1.000 |
| 9:122911041:G:C | H344Q | 1.000 |
| 9:122911041:G:T | H344Q | 1.000 |
| 9:122911043:G:C | H344D | 1.000 |
| 9:122911045:C:G | R343P | 1.000 |
| 9:122911051:A:G | L341P | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000074128 (9:122908471 A>C,G), RS1000862254 (9:122914531 GTAA>G), RS1002385562 (9:122910118 G>A), RS1002414909 (9:122909853 A>G), RS1002810229 (9:122909670 A>G), RS1003057670 (9:122913490 G>C), RS1003088887 (9:122913299 C>G), RS1003390406 (9:122912143 A>C,G), RS1003756288 (9:122911808 A>G), RS1004023820 (9:122915260 T>C,G), RS1004257620 (9:122915019 T>TC), RS1004435384 (9:122908541 A>G), RS1004714336 (9:122914814 CTCAG>C), RS1004940010 (9:122908344 T>C), RS1005971152 (9:122909535 A>G)
Disease associations
OMIM: gene MIM:605976 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_64 | Body mass index | 2.000000e-10 |
| GCST010703_296 | Brain morphology (MOSTest) | 2.000000e-14 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression | 3 |
| sodium arsenite | decreases expression, increases abundance, increases expression | 2 |
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Tobacco Smoke Pollution | increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| TL8-506 | affects cotreatment, increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Silicon Dioxide | increases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin M1 | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XV93 | HEK293 eGFP-ZBTB6 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.